Mainz Biomed NV

자세한 내용은 Mainz Biomed NV 회사

Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.

회사 정보

종목 코드 MYNZ

회사 이름Mainz Biomed NV

상장일Nov 04, 2021

CEOMr. Guido Baechler

직원 수19

유형Ordinary Share

회계 연도 종료Nov 04

주소Sirius Gutenberg Park

도시MAINZ

증권 거래소NASDAQ Capital Market Consolidated

국가Germany

우편 번호55129

전화4961315542860

웹사이트https://www.mainzbiomed.com/

종목 코드 MYNZ

상장일Nov 04, 2021

CEOMr. Guido Baechler

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Guido Baechler

Chief Executive Officer, Executive Director

20.06K

+6.65%

Mr. Hans Hekland

Non-Executive Independent Director

17.77K

-0.84%

Dr. Chris von Toerne

Chief Operating Officer

2.50K

+1379.29%

Dr. Heiner Dreismann, Ph.D.

Non-Executive Independent Director

2.20K

--

Mr. William Caragol

Chief Financial Officer

--

Mr. Gregory J. (Greg) Tibbitts

Non-Executive Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Guido Baechler

Chief Executive Officer, Executive Director

20.06K

+6.65%

Mr. Hans Hekland

Non-Executive Independent Director

17.77K

-0.84%

Dr. Chris von Toerne

Chief Operating Officer

2.50K

+1379.29%

Dr. Heiner Dreismann, Ph.D.

Non-Executive Independent Director

2.20K

--

Mr. William Caragol

Chief Financial Officer

--

Mr. Gregory J. (Greg) Tibbitts

Non-Executive Independent Director

--

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Fri, May 16

주주

주주 유형

주주

비율

Armistice Capital LLC

5.15%

Fur Wiederaufbau (Kredianstalt)

0.61%

Morgan Stanley & Co. LLC

0.58%

Baechler (Guido)

0.53%

Hekland (Hans)

0.47%

Other

92.66%

주주

비율

Armistice Capital LLC

5.15%

Fur Wiederaufbau (Kredianstalt)

0.61%

Morgan Stanley & Co. LLC

0.58%

Baechler (Guido)

0.53%

Hekland (Hans)

0.47%

Other

92.66%

주주 유형

주주

비율

Hedge Fund

5.15%

Individual Investor

1.95%

Research Firm

0.85%

Investment Advisor

0.13%

Other

91.92%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

34

308.42K

8.08%

-19.73K

2025Q1

40

350.55K

9.90%

-3.02K

2024Q4

40

356.23K

16.03%

+257.88K

2024Q3

37

115.45K

5.70%

+19.26K

2024Q2

34

120.95K

9.96%

+24.53K

2024Q1

36

122.04K

10.26%

+25.33K

2023Q4

27

96.56K

23.08%

+9.46K

2023Q3

22

91.42K

24.64%

+4.27K

2023Q2

22

91.39K

24.65%

+4.22K

2023Q1

19

86.84K

24.47%

+12.12K

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Armistice Capital LLC

196.60K

5.15%

-25.40K

-11.44%

Mar 31, 2025

Fur Wiederaufbau (Kredianstalt)

23.20K

0.61%

-7.74K

-25.00%

Sep 30, 2024

Morgan Stanley & Co. LLC

22.20K

0.58%

+22.20K

--

Mar 31, 2025

Baechler (Guido)

20.06K

0.53%

+1.25K

+6.65%

Mar 21, 2025

Hekland (Hans)

17.77K

0.47%

-151.00

-0.84%

Mar 21, 2025

Virtu Americas LLC

10.23K

0.27%

-8.10K

-44.17%

Mar 31, 2025

Caragol (William J)

7.90K

0.21%

+2.58K

+48.56%

Mar 21, 2025

von Toerne (Chris)

2.50K

0.07%

+2.33K

+1379.29%

Mar 21, 2025

Dreismann (Heiner)

2.20K

0.06%

--

Mar 21, 2025

UBS Financial Services, Inc.

1.91K

0.05%

-1.85K

-49.20%

Mar 31, 2025

1.400USD

Mainz Biomed NV

1.400

개요

회사

금융